9013 POSTER DISCUSSION Phase I Dose-escalation Study of AXL1717: a Novel Targeted Oral Insulin-like Growth Factor-1 Receptor (IGF-1R) Inhibitor and Its Implications for Patients With Non-small Cell Lung Carcinoma
2011 ◽
Vol 47
◽
pp. S595-S596
◽
Keyword(s):
Phase I
◽
2005 ◽
Vol 61
(2)
◽
pp. 318-328
◽
2010 ◽
Vol 28
(15_suppl)
◽
pp. e13019-e13019
Prohormone convertase and autocrine growth factor mRNAs are coexpressed in small cell lung carcinoma
2000 ◽
Vol 25
(1)
◽
pp. 121-128
◽
1999 ◽
Vol 96
(26)
◽
pp. 14894-14898
◽
1999 ◽
Vol 11
(4)
◽
pp. 288-291
◽
1998 ◽
Vol 34
(5)
◽
pp. 718-723
◽